News Opinion CV Team Dispatch September 2024 Dispatch for the CV Team L.A. McKeown September 01, 2024
News Conference News ESC 2024 Getting to Cholesterol Goal Early After MI Lowers Risk of Recurrent Events Michael O'Riordan September 01, 2024
News Conference News ESC 2024 Three Common Biomarkers Closely Tied to Women’s 30-Year Risk of CV Events Caitlin E. Cox August 31, 2024
News Conference News ESC 2024 New BedMed Data Confirm Antihypertensives Can Be Taken Any Time of Day Yael L. Maxwell August 31, 2024
News Daily News Good News for CV Recovery After COVID-19 Vaccine Myocarditis Yael L. Maxwell August 29, 2024
News Daily News AUGUSTUS Analysis Clarifies Antithrombotic Choice for ACS in AF Patients Michael O'Riordan August 26, 2024
News Daily News Scientific Statement Reviews Current Antithrombotic Options in PAD L.A. McKeown August 26, 2024
News Daily News ‘Disproportionate’ Suicide/Self-Harm Signal With Semaglutide: WHO Database Michael O'Riordan August 21, 2024
News Daily News Lp(a) Still Low Almost 1 Year After Last Olpasiran Injection: OCEAN(a)-DOSE Yael L. Maxwell August 19, 2024
News Daily News Tirzepatide Provides Sustained BP Reduction in Overweight Adults Todd Neale August 15, 2024
News Daily News PREVENT Risk Calculator Means Fewer Patients on Statins, Antihypertensives Michael O'Riordan August 02, 2024
News Daily News Apixaban May Have Advantages in Patients With Liver Cirrhosis and AF Michael O'Riordan July 09, 2024
News Daily News Aligning Pill Burden and Palliative Care Needs in Late-Stage CVD: AHA L.A. McKeown July 02, 2024
News Daily News ‘Provocative’ Projections See Semaglutide Slashing CV Events in Adults With ASCVD Todd Neale June 27, 2024
News Conference News NY Valves 2024 Polymer Mitral Valve Shows Well Early, but Long-term Data Key Michael O'Riordan June 12, 2024
News Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia Michael O'Riordan May 30, 2024
News Conference News ESOC 2024 TEMPO-2: Tenecteplase No Help in Mild Stroke With Proven Occlusion Todd Neale May 23, 2024